Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.

CONCLUSIONS: Platinum-based NAC was associated with similar survival benefit as patients undergoing cystectomy and/or radiotherapy. No conclusion can be drawn about the optimal platinum-based combination to be used in the neoadjuvant setting. PMID: 28447581 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28447581?dopt=Abstract

Source: Clinical and Investigative Medicine - April 26, 2017 Category: Biomedical Science Authors: Li G, Niu HM, Wu HT, Lei BY, Wang XH, Guo XB, Feng SL Tags: Clin Invest Med Source Type: research